Shareholders' equity · 2011–2025
Supernus Pharmaceuticals shareholders' equity
$1.1B+2.5% · FY2025
Supernus Pharmaceuticals (SUPN) reported $1.1B in shareholders' equity for fiscal 2025, +2.5% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $1.1B | +2.5% | Open → |
| FY20242024-12-31 | $1.0B | +12.4% | Open → |
| FY20232023-12-31 | $922M | +4.0% | Open → |
| FY20222022-12-31 | $886M | +8.6% | Open → |
| FY20212021-12-31 | $816M | +9.5% | Open → |
| FY20202020-12-31 | $745M | +25.1% | Open → |
| FY20192019-12-31 | $595M | +31.4% | Open → |
| FY20182018-12-31 | $453M | +69.4% | Open → |
| FY20172017-12-31 | $267M | +39.5% | Open → |
| FY20162016-12-31 | $192M | +117.9% | Open → |
| FY20152015-12-31 | $88.0M | +116.2% | Open → |
| FY20142014-12-31 | $40.7M | +21.6% | Open → |
| FY20132013-12-31 | $33.5M | −41.9% | Open → |
| FY20122012-12-31 | $57.6M | +509.7% | Open → |
| FY20112011-12-31 | $9.4M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +40.1%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Supernus Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/supernus-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Supernus Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/supernus-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-supernus-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Supernus Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/supernus-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001356576-26-000037 · August 3, 2026
{{cite web |title=Supernus Pharmaceuticals shareholders' equity — 10-Q (0001356576-26-000037) |url=https://www.sec.gov/Archives/edgar/data/1356576/000135657626000037/supn-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-03}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.